Symptom-centric view

Deep vein thrombosis

Substances reporting Deep vein thrombosis disproportionately — ranked by ROR.

Pain Drug ineffective Off label use Fatigue Dyspnoea Acute kidney injury

showing 45 of 45

Substance ↓	ROR [95% CI]	Reports	Category	Label
warfarin sodium —	6.4 [6.0–6.9]	902	algemeen	new
warfarin —	5.0 [4.7–5.2]	1,907	algemeen	new
thalidomide —	7.6 [7.1–8.1]	840	algemeen	new
testosterone cypionate —	24.7 [22.8–26.8]	620	algemeen	new
testosterone —	15.9 [15.3–16.6]	2,396	algemeen	new
temozolomide —	4.3 [3.8–4.8]	272	algemeen	new
sipuleucel-t —	4.0 [3.2–5.1]	70	algemeen	new
romiplostim —	6.6 [5.9–7.4]	297	algemeen	new
rivaroxaban —	8.9 [8.6–9.1]	5,173	algemeen	new
relugolix, estradiol hemihydrate, and norethindrone acetate —	2.8 [1.6–4.9]	13	algemeen	new
raloxifene hydrochloride —	6.9 [6.2–7.8]	308	algemeen	new
raloxifene —	6.4 [5.7–7.2]	315	algemeen	new
phentermine hydrochloride —	6.6 [5.6–7.9]	128	algemeen	new
norgestimate and ethinyl estradiol —	4.4 [3.5–5.7]	62	algemeen	new
norethindrone and ethinyl estradiol —	6.2 [4.1–9.4]	22	algemeen	new
megestrol acetate —	9.1 [7.5–11.0]	105	algemeen	new
medroxyprogesterone acetate —	3.9 [3.6–4.2]	625	algemeen	new
lenalidomide —	3.5 [3.4–3.7]	4,354	algemeen	new
ibuprofen capsule, liquid-filled —	5.3 [4.1–6.8]	64	algemeen	new
ibuprofen and diphenhydramine citrate —	8.1 [7.4–8.8]	566	algemeen	new
heparin sodium —	6.9 [6.1–7.7]	292	algemeen	new
gemcitabine hydrochloride —	4.0 [3.7–4.3]	634	algemeen	new
gemcitabine —	4.0 [3.7–4.3]	634	algemeen	new
fondaparinux sodium —	12.1 [10.8–13.6]	294	algemeen	new
ferrous asparto glycinate, iron, ascorbic acid, folic acid, cyanocobalamin, zinc, and succinic acid —	9.4 [5.8–15.2]	17	algemeen	new
etonogestrel and ethinyl estradiol —	45.4 [43.6–47.3]	2,661	algemeen	new
etonogestrel —	13.5 [13.0–14.1]	2,722	algemeen	new
estradiol —	25.3 [24.8–25.8]	11,712	algemeen	new
enoxaparin sodium —	8.7 [8.3–9.2]	1,482	algemeen	new
elotuzumab —	3.5 [2.7–4.5]	55	algemeen	new
drospirenone and ethinyl estradiol —	83.3 [81.2–85.4]	8,392	algemeen	new
drospirenone —	72.0 [70.3–73.8]	8,519	algemeen	new
diflorasone diacetate —	7.0 [2.6–18.9]	4	algemeen	new
daprodustat —	5.0 [3.4–7.3]	27	algemeen	new
dalteparin sodium —	9.6 [8.6–10.8]	303	algemeen	new
dabigatran etexilate mesylate —	4.2 [3.9–4.5]	925	algemeen	new
dabigatran etexilate —	4.3 [4.1–4.6]	1,042	algemeen	new
conjugated estrogens and medroxyprogesterone acetate —	5.5 [5.0–6.1]	397	algemeen	new
colloidal oatmeal —	9.1 [4.3–19.4]	7	algemeen	new
carfilzomib —	3.6 [3.2–4.1]	312	algemeen	new
canakinumab —	10.4 [9.3–11.6]	336	algemeen	new
bleomycin sulfate —	3.6 [3.0–4.3]	114	algemeen	new
bleomycin —	3.6 [3.0–4.3]	114	algemeen	new
baricitinib —	7.4 [6.4–8.5]	213	algemeen	new
apixaban —	4.9 [4.6–5.3]	973	algemeen	new

ROR = reporting odds ratio vs. the full FAERS corpus. A signal is not a cause. Source: openFDA (FAERS).